Becton Dickinson Current Ratio 2012-2025 | BDX
Current and historical current ratio for Becton Dickinson (BDX) from 2012 to 2025. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Becton Dickinson current ratio for the three months ending September 30, 2025 was 1.11.
| Becton Dickinson Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2025-09-30 | $9.26B | $8.31B | 1.11 |
| 2025-06-30 | $9.00B | $8.16B | 1.10 |
| 2025-03-31 | $8.67B | $7.69B | 1.13 |
| 2024-12-31 | $8.66B | $7.66B | 1.13 |
| 2024-09-30 | $10.47B | $8.96B | 1.17 |
| 2024-06-30 | $12.21B | $6.61B | 1.85 |
| 2024-03-31 | $10.34B | $7.33B | 1.41 |
| 2023-12-31 | $8.16B | $7.54B | 1.08 |
| 2023-09-30 | $8.68B | $6.64B | 1.31 |
| 2023-06-30 | $8.59B | $6.88B | 1.25 |
| 2023-03-31 | $9.59B | $7.30B | 1.31 |
| 2022-12-31 | $8.18B | $7.63B | 1.07 |
| 2022-09-30 | $8.14B | $7.81B | 1.04 |
| 2022-06-30 | $9.55B | $7.08B | 1.35 |
| 2022-03-31 | $10.15B | $6.66B | 1.53 |
| 2021-12-31 | $8.31B | $6.74B | 1.23 |
| 2021-09-30 | $8.84B | $6.63B | 1.33 |
| 2021-06-30 | $9.54B | $7.75B | 1.23 |
| 2021-03-31 | $10.00B | $5.38B | 1.86 |
| 2020-12-31 | $9.54B | $7.02B | 1.36 |
| 2020-09-30 | $8.97B | $5.84B | 1.54 |
| 2020-06-30 | $8.83B | $6.07B | 1.46 |
| 2020-03-31 | $8.56B | $8.76B | 0.98 |
| 2019-12-31 | $6.44B | $6.73B | 0.96 |
| 2019-09-30 | $6.66B | $5.66B | 1.18 |
| 2019-06-30 | $6.78B | $6.24B | 1.09 |
| 2019-03-31 | $6.84B | $7.11B | 0.96 |
| 2018-12-31 | $6.94B | $7.15B | 0.97 |
| 2018-09-30 | $7.41B | $7.22B | 1.03 |
| 2018-06-30 | $7.53B | $6.11B | 1.23 |
| 2018-03-31 | $7.51B | $4.43B | 1.70 |
| 2017-12-31 | $7.54B | $4.90B | 1.54 |
| 2017-09-30 | $18.63B | $3.34B | 5.58 |
| 2017-06-30 | $18.21B | $3.27B | 5.56 |
| 2017-03-31 | $4.89B | $4.02B | 1.22 |
| 2016-12-31 | $5.19B | $4.57B | 1.14 |
| 2016-09-30 | $6.37B | $4.40B | 1.45 |
| 2016-06-30 | $6.53B | $4.22B | 1.55 |
| 2016-03-31 | $6.61B | $4.38B | 1.51 |
| 2015-12-31 | $5.64B | $4.53B | 1.25 |
| 2015-09-30 | $5.66B | $4.38B | 1.29 |
| 2015-06-30 | $6.30B | $4.52B | 1.40 |
| 2015-03-31 | $7.00B | $4.50B | 1.56 |
| 2014-12-31 | $12.11B | $2.08B | 5.82 |
| 2014-09-30 | $6.13B | $2.24B | 2.74 |
| 2014-06-30 | $6.05B | $2.09B | 2.89 |
| 2014-03-31 | $5.95B | $2.02B | 2.95 |
| 2013-12-31 | $5.74B | $2.00B | 2.88 |
| 2013-09-30 | $5.87B | $2.13B | 2.76 |
| 2013-06-30 | $5.44B | $1.69B | 3.21 |
| 2013-03-31 | $5.50B | $1.88B | 2.93 |
| 2012-12-31 | $5.48B | $2.00B | 2.73 |
| 2012-09-30 | $5.32B | $1.98B | 2.69 |
| 2012-06-30 | $5.29B | $1.89B | 2.80 |
| 2012-03-31 | $5.30B | $1.62B | 3.27 |
| 2011-12-31 | $5.69B | $1.61B | 3.55 |
| 2011-09-30 | $4.67B | $1.82B | 2.56 |
| 2011-06-30 | $5.07B | $1.66B | 3.06 |
| 2011-03-31 | $4.86B | $1.58B | 3.08 |
| 2010-12-31 | $4.95B | $1.61B | 3.07 |
| 2010-09-30 | $4.51B | $1.67B | 2.70 |
| 2010-06-30 | $4.12B | $1.53B | 2.69 |
| 2010-03-31 | $3.94B | $1.47B | 2.69 |
| 2009-12-31 | $4.06B | $1.54B | 2.64 |
| 2009-09-30 | $4.65B | $1.78B | 2.62 |
| 2009-06-30 | $4.49B | $1.65B | 2.73 |
| 2009-03-31 | $3.41B | $1.51B | 2.26 |
| 2008-12-31 | $3.47B | $1.64B | 2.12 |
| 2008-09-30 | $3.62B | $1.42B | 2.55 |
| 2008-06-30 | $3.65B | $1.47B | 2.49 |
| 2008-03-31 | $3.42B | $1.38B | 2.48 |
| 2007-12-31 | $3.35B | $1.50B | 2.24 |
| 2007-09-30 | $3.13B | $1.48B | 2.12 |
| 2007-06-30 | $2.96B | $1.42B | 2.09 |
| 2007-03-31 | $2.85B | $1.35B | 2.12 |
| 2006-12-31 | $2.83B | $1.47B | 1.92 |
| 2006-09-30 | $3.19B | $1.58B | 2.02 |
| 2006-06-30 | $2.82B | $1.37B | 2.07 |
| 2006-03-31 | $2.81B | $1.29B | 2.18 |
| 2005-12-31 | $3.15B | $1.55B | 2.03 |
| 2005-09-30 | $2.98B | $1.30B | 2.29 |
| 2005-06-30 | $2.95B | $1.26B | 2.34 |
| 2005-03-31 | $2.89B | $1.14B | 2.54 |
| 2004-12-31 | $2.82B | $1.17B | 2.42 |
| 2004-09-30 | $2.64B | $1.05B | 2.52 |
| 2004-06-30 | $2.51B | $1.01B | 2.50 |
| 2004-03-31 | $2.48B | $0.89B | 2.79 |
| 2003-12-31 | $2.37B | $0.94B | 2.52 |
| 2003-09-30 | $2.50B | $1.06B | 2.36 |
| 2003-06-30 | $2.36B | $1.01B | 2.33 |
| 2003-03-31 | $2.09B | $1.31B | 1.59 |
| 2002-12-31 | $1.93B | $1.28B | 1.51 |
| 2002-09-30 | $1.92B | $1.25B | 1.54 |
| 2002-06-30 | $1.84B | $1.28B | 1.43 |
| 2002-03-31 | $1.81B | $1.34B | 1.35 |
| 2001-12-31 | $1.72B | $1.31B | 1.31 |
| 2001-09-30 | $1.76B | $1.27B | 1.39 |
| 2001-06-30 | $1.74B | $1.26B | 1.38 |
| 2001-03-31 | $1.72B | $1.31B | 1.32 |
| 2000-12-31 | $1.72B | $1.36B | 1.26 |
| 2000-09-30 | $1.66B | $1.35B | 1.23 |
| 2000-06-30 | $1.71B | $1.44B | 1.19 |
| 2000-03-31 | $1.71B | $1.47B | 1.17 |
| 1999-12-31 | $1.70B | $1.36B | 1.26 |
| 1999-09-30 | $1.68B | $1.33B | 1.27 |
| 1999-06-30 | $1.59B | $1.26B | 1.27 |
| 1999-03-31 | $1.63B | $1.30B | 1.26 |
| 1998-12-31 | $1.59B | $1.12B | 1.42 |
| 1998-09-30 | $1.54B | $1.09B | 1.41 |
| 1998-06-30 | $1.49B | $1.08B | 1.38 |
| 1998-03-31 | $1.31B | $0.76B | 1.74 |
| 1997-12-31 | $1.28B | $0.67B | 1.92 |
| 1997-09-30 | $1.31B | $0.68B | 1.94 |
| 1997-06-30 | $1.31B | $0.85B | 1.54 |
| 1997-03-31 | $1.24B | $0.66B | 1.88 |
| 1996-12-31 | $1.22B | $0.68B | 1.81 |
| 1996-09-30 | $1.28B | $0.77B | 1.67 |
| 1996-06-30 | $1.32B | $0.89B | 1.49 |
| 1996-03-31 | $1.25B | $0.72B | 1.75 |
| 1995-12-31 | $1.28B | $0.71B | 1.82 |
| 1995-09-30 | $1.33B | $0.72B | 1.84 |
| 1995-06-30 | $1.32B | $0.72B | 1.83 |
| 1995-03-31 | $1.26B | $0.70B | 1.81 |
| 1994-12-31 | $1.24B | $0.68B | 1.81 |
| 1994-09-30 | $1.33B | $0.68B | 1.96 |
| 1994-06-30 | $1.17B | $0.56B | 2.07 |
| 1994-03-31 | $1.08B | $0.57B | 1.91 |
| 1993-12-31 | $1.08B | $0.58B | 1.86 |
| 1993-09-30 | $1.15B | $0.64B | 1.81 |
| 1993-06-30 | $1.14B | $0.54B | 2.11 |
| 1993-03-31 | $1.22B | $0.63B | 1.95 |
| 1992-12-31 | $1.15B | $0.65B | 1.79 |
| 1992-09-30 | $1.22B | $0.71B | 1.71 |
| 1992-06-30 | $1.15B | $0.73B | 1.57 |
| 1992-03-31 | $1.09B | $0.65B | 1.68 |
| 1991-12-31 | $1.07B | $0.62B | 1.73 |
| 1991-09-30 | $1.03B | $0.53B | 1.94 |
| 1991-06-30 | $0.99B | $0.49B | 2.04 |
| 1991-03-31 | $1.03B | $0.53B | 1.95 |
| 1990-12-31 | $0.97B | $0.57B | 1.72 |
| 1990-09-30 | $0.96B | $0.57B | 1.68 |
| 1990-06-30 | $0.91B | $0.60B | 1.52 |
| 1990-03-31 | $0.92B | $0.60B | 1.54 |
| 1989-12-31 | $0.88B | $0.57B | 1.54 |
| 1989-09-30 | $0.87B | $0.57B | 1.53 |
| 1989-06-30 | $0.84B | $0.55B | 1.53 |
| 1989-03-31 | $0.86B | $0.62B | 1.39 |
| 1988-12-31 | $0.91B | $0.58B | 1.56 |
| 1988-09-30 | $0.88B | $0.53B | 1.68 |
| 1988-06-30 | $0.82B | $0.51B | 1.60 |
| 1988-03-31 | $0.84B | $0.53B | 1.59 |
| 1987-12-31 | $0.82B | $0.51B | 1.61 |
| 1987-09-30 | $0.84B | $0.49B | 1.71 |
| 1987-06-30 | $0.79B | $0.44B | 1.80 |
| 1987-03-31 | $0.82B | $0.51B | 1.62 |
| 1986-12-31 | $0.79B | $0.46B | 1.70 |
| 1986-09-30 | $0.78B | $0.45B | 1.76 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $59.836B | $21.840B |
| Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional. BD Medical: BD Medical's major product lines include needles, syringes and intravenous catheters for medication delivery and generic prefilled injectables. BD Life Sciences - BD Diagnostics provides products for the safe collection and transport of diagnostics specimens to detect a broad range of infectious diseases, healthcare-associated infections and cancer. BD Biosciences produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. With the acquisition of C.R. Bard, BD added a new segment - BD Interventional. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $116.201B | 25.24 |
| Cardinal Health (CAH) | United States | $53.257B | 23.55 |
| West Pharmaceutical Services (WST) | United States | $17.910B | 35.21 |
| Cooper (COO) | United States | $16.090B | 19.88 |
| Align Technology (ALGN) | United States | $13.460B | 22.85 |
| Henry Schein (HSIC) | United States | $9.385B | 16.54 |
| Merit Medical Systems (MMSI) | United States | $4.891B | 24.05 |
| DENTSPLY SIRONA (XRAY) | United States | $2.745B | 8.71 |
| CONMED (CNMD) | United States | $1.286B | 9.01 |
| STAAR Surgical (STAA) | United States | $0.874B | 0.00 |
| Pro-Dex (PDEX) | United States | $0.126B | 15.06 |
| Lifevantage (LFVN) | United States | $0.064B | 6.62 |
| Axe Compute (AGPU) | United States | $0.008B | 0.00 |